GetTopicDetailResponse(id=498799968fe, topicName=靶點(diǎn)新藥, introduction=靶點(diǎn)新藥, content=null, image=null, comments=3, allHits=783, url=https://h5.medsci.cn/topic?id=99968, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=95599, tagList=[TagDto(tagId=95599, tagName=靶點(diǎn)新藥)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1819857, encodeId=9e2f181985e20, content=<a href='/topic/show?id=498799968fe' target=_blank style='color:#2F92EE;'>#靶點(diǎn)新藥#</a>, objectTitle=肝膽領(lǐng)域值得期待三大靶點(diǎn)新藥介紹，讓肝癌患者有更多的選擇！, objectType=article, longId=193462, objectId=57141934627d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=57141934627d, replyNumber=0, likeNumber=95, createdTime=2021-04-13, rootId=0, userName=醫(yī)生2394, userId=b505306, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=57141934627d, moduleTitle=肝膽領(lǐng)域值得期待三大靶點(diǎn)新藥介紹，讓肝癌患者有更多的選擇！, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=57141934627d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819856, encodeId=ec001819856fd, content=<a href='/topic/show?id=498799968fe' target=_blank style='color:#2F92EE;'>#靶點(diǎn)新藥#</a>, objectTitle=Mol Cancer Ther:對抗三陰乳腺癌化療耐藥性，MPS1靶點(diǎn)新藥“重振”紫杉醇功效, objectType=article, longId=181276, objectId=58ec1812e693, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=58ec1812e693, replyNumber=0, likeNumber=95, createdTime=2020-09-27, rootId=0, userName=醫(yī)生2394, userId=b505306, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=58ec1812e693, moduleTitle=Mol Cancer Ther:對抗三陰乳腺癌化療耐藥性，MPS1靶點(diǎn)新藥“重振”紫杉醇功效, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=58ec1812e693)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819855, encodeId=7de01819855b5, content=<a href='/topic/show?id=498799968fe' target=_blank style='color:#2F92EE;'>#靶點(diǎn)新藥#</a>, objectTitle=十大熱門靶點(diǎn)新藥銷售收入對比, objectType=article, longId=161395, objectId=f06c1613956c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f06c1613956c, replyNumber=0, likeNumber=83, createdTime=2019-11-22, rootId=0, userName=醫(yī)生2394, userId=b505306, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f06c1613956c, moduleTitle=十大熱門靶點(diǎn)新藥銷售收入對比, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=f06c1613956c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
